International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J. Thromb. Haemost, vol.4, pp.295-306, 2006. ,
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop, Arthritis Rheum, vol.42, pp.1309-1311, 1999. ,
Systematic review of case reports of antiphospholipid syndrome following infection, Lupus, vol.25, pp.1520-1531, 2016. ,
Clinical application of revised laboratory classification criteria for antiphospholipid antibody syndrome: is the follow-up interval of 12 weeks instead of 6 weeks significantly useful?, Biomed Res Int, p.2641526, 2016. ,
Comparison of the 1999 Sapporo and 2006 revised criteria for the classification of the antiphospholipid syndrome, Clin. Exp. Rheumatol, vol.27, pp.914-919, 2009. ,
Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile, J. Thromb. Haemost, vol.11, pp.1527-1531, 2013. ,
Diagnostics and treatment of thrombotic antiphopholipid syndrome (APS): a personal perspective, Thrombosis Research, vol.169, pp.35-40, 2018. ,
Update of the guidelines for lupus anticoagulant detection. Subcommittee on lupus anticoagulant/antiphospholipid antibody of the scientific and standardisation committee of the international society on thrombosis and haemostasis, J. Thromb. Haemost, vol.7, pp.1737-1740, 2009. ,
, International consensus guidelines on anticardiolipin and anti-?2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies, vol.64, pp.1-10, 2012.
Definition and significance of high positivity aCL ELISA, Lupus, vol.21, pp.725-726, 2012. ,